scispace - formally typeset
Search or ask a question
Topic

Arecoline

About: Arecoline is a research topic. Over the lifetime, 744 publications have been published within this topic receiving 16015 citations. The topic is also known as: methylarecaiden & methylarecaidin.


Papers
More filters
Journal ArticleDOI
TL;DR: A proteome of oral cancer cells that is associated with chronic areca nut exposure is identified and Krt17 was demonstrated to contribute to areca Nut-induced oral malignancy.
Abstract: The areca nut is a known carcinogen that causes oral cancer in individuals in Southeast Asia, but the molecular mechanism that leads to this malignancy is still unclear. To mimic the habit of areca nut chewing, our laboratory has established four oral cancer cell sublines (SAS, OECM1, K2, C9), which have been chronically exposed to areca nut extract (ANE). To elucidate the molecular basis of areca nut-induced oral carcinogenesis, the differential proteomes between oral cancer cells and the ANE-treated sublines were determined using isobaric mass tag (iTRAQ) labeling and multidimensional liquid chromatography-mass spectrometry (LC-MS/MS). Over 1000 proteins were identified in four sublines, and 196 proteins were found to be differentially expressed in at least two ANE-treated sublines. A bioinformatic analysis revealed that these proteins participate in several pathways, and one of the most prominent pathways was the regulation of epithelial to mesenchymal transition (EMT). In all, 24 proteins including Krt17 were confirmed to be differentially expressed in the ANE-treated sublines. To reveal additional information on the mechanism of ANE-induced carcinogenesis, Krt17 was further investigated. Krt17 knockdown significantly suppressed ANE-induced cell migration and invasion and modulated the EMT process. Furthermore, in a murine model of carcinogen-induced (arecoline cocktail, an active compound of ANE) oral cancer, Krt17 was significantly up-regulated in all hyperplastic tissues and in carcinoma tissues (p < 0.001). In conclusion, we have identified a proteome of oral cancer cells that is associated with chronic areca nut exposure. Krt17 was demonstrated to contribute to areca nut-induced oral malignancy. The results of this study contribute to risk assessment, disease prevention and other clinical applications associated with areca nut-induced oral cancer.

27 citations

Journal ArticleDOI
TL;DR: EGCG can be a useful agent in the chemoprevention and treatment of OSF after it was indicated that arecoline-induced mitochondrial ROS plays pivotal roles in the activation of latent TGF β1 leading to the initiation of TGFβ1 signaling and subsequent increase in the synthesis of CCN2 and Egr-1.

27 citations

Journal ArticleDOI
TL;DR: The data demonstrate that the DS effect of arecoline depends on central muscarinic receptors, and that it completely generalized to oxotremorine, partially generalized to pilocarpine, and did not generalize to nicotine.
Abstract: Rats were trained to discriminate arecoline (1.74 mg/kg) from saline in a milk-reinforced (variable interval 12 s) two-lever operant paradigm. The discriminative stimulus (DS) effects of arecoline were antagonized by atropine sulfate, but not by atropine methylnitrate or mecamylamine. In contrast to the effects on discrimination, atropine did not antagonize the response rate suppressant effects of arecoline. The DS effect of arecoline completely generalized to oxotremorine, partially generalized to pilocarpine, and did not generalize to nicotine. These data demonstrate that the DS effect of arecoline depends on central muscarinic receptors.

27 citations

Journal ArticleDOI
TL;DR: It is concluded that choline esters, applied intraventricularly to unanaesthetized cats, elicit excitant behavioural phenomena by an action on central muscarinic cholinoceptive sites.

27 citations

Journal ArticleDOI
TL;DR: In this article, a series of 1-alkyl-1,2,5,6-tetrahydropyridine-3-carboxaldehyde- O -alkyloximes was synthesized and biologically evaluated in a battery of in vitro and in vivo assays.

27 citations


Network Information
Related Topics (5)
Dopamine
45.7K papers, 2.2M citations
70% related
Receptor
159.3K papers, 8.2M citations
69% related
Agonist
53.7K papers, 1.9M citations
68% related
In vivo
61.3K papers, 1.9M citations
66% related
Glutamate receptor
33.5K papers, 1.8M citations
65% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
202335
202243
202126
202038
201921
201818